NIFTY 50
24,565.35 (-0.82%)
NIFTY IT
34,649.60 (-1.85%)
NIFTY AUTO
23,410.95 (-1.04%)
NIFTY FINANCIAL SERVICES
26,492.50 (-0.59%)
NIFTY BANK
55,617.60 (-0.62%)
NIFTY REALTY
896.15 (-1.78%)
NIFTY ENERGY
34,889.00 (-0.65%)
NIFTY METAL
9,102.35 (-1.97%)
NIFTY FMCG
56,197.05 (0.69%)
NIFTY HEALTH CARE
14,468.70 (-2.77%)
NIFTY PHARMA
22,011.70 (-3.33%)
NIFTY MEDIA
22,011.70 (-3.33%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

   Company Background
Change Company Name
Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524715 ISIN Demat INE044A01036 Book Value 101.44 NSE Symbol SUNPHARMA Dividend Yield (%) 0.98 Market Cap (₹ Cr.) 390,863.66 P/E 78.47 EPS 20.76 Face Value 1
Incorporation Year 1993
Registered Office Sun Pharma Advanced Res.Centre,Tandalja,
Vadodara,
Gujarat-390020
Telephone 91-265-6615500
Fax 91-265-2354897
Chairman Dilip S Shanghvi
Managing Director Dilip S Shanghvi
Company Secretary Anoop Deshpande
Auditor S R B C & Co LLP
Face Value 1
Market Lot 1
Listing BSE,MSEI ,NSE
Registrar MUFG Intime India Pvt Ltd
C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083
About INVES 21
Insights

S A Artha Securities Private Limited,
CIN: U65900TG2022PTC167512.
Registered Office: Flat No.202A, La Paloma Caves, Road No 12, Banjara Hills, Hyderabad, Telangana- 500034,
Correspondence Office: 8-2-269/S/91/B, Sagar Society, Road No.2, Banjara Hills,Banjara Hills,HYDERABAD,500034
Tel No: 040-48444546.
SEBI Reg. No: NSE: INZ000316838 | BSE Member Code: 6902 | SEBI Reg. No: Research Analyst: INH000016667 | Mutual Fund Distributor: AMFI Reg. No ARN- 279815
SEBI Reg. No: Depository Participant (NSDL): IN-DP-776-2024 | Member: NSE - TM Code-90369.

Details of Client Bank Account
For any query / feedback / clarification, email at info@inves21.com

In case of grievance for any of the services rendered by S A Artha Securities Private Limited, please write to grievance@inves21.com (for NSE). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms & Conditions, and Privacy Policy. Compliance Officer: Mahananda Samsani, E-mail address: compliance@inves21.com. To lodge your complaints using SEBI SCORES, Click here.

Procedure to file a complaint on SEBI SCORES:
- Register on SCORES portal.
- Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID.
- Benefits: Effective Communication, Speedy redressal of grievances.

Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit.

Attention investors:

  • Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w. e. f. September 01, 2020   
  • Update your e-mail and phone number with your stock broker/ depository participant and receive OTP directly from the depository on your e-mail and / or mobile number to create a pledge.
  • Check your securities/ MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: To prevent unauthorized transactions in your account. Update your mobile number/email IDs with your stock brokers. Receive information on your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets. Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach an intermediary. “Dear investor, if you are subscribing to an IPO, there is no need to issue a cheque. Please write the bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non-allotment, the funds will remain in your bank account.
S A Artha Securities Private Limited is a distributor of Mutual funds. Mutual fund investments are subject to market risks, and all disputes with respect to the distribution activity would not have access to the Exchange investor redressal forum or Arbitration mechanism. Please read all scheme-related documents carefully before investing. The past performance of the schemes is neither an indicator nor a guarantee of future performance.
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: NSE

Kindly read the Advisory Guidelines of NSE for investors as prescribed by the exchange with reference to their circular dated 27th August 2021 regarding investor awareness and safeguarding client’s assets.

  • Copyright © 2024   INVES 21
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)